Netizens expressed displeasure over a coffee shop franchisee’s move to classify vaccinated and non-vaccinated customers by color-coding their cups.
According to a post, the barista would ask customers about their vaccination status and classify them as vaccinated with green stickers and non-vaccinated with yellow stickers.
The company’s customer service department explained that they were following a company procedure to ascertain each customer’s quarantine status and maintain a safe environment.
It emphasized that discrimination was not their intent.
Meanwhile, the franchisee pointed out that the policy was necessary as the coffee shop owners risk being penalized if customers violate quarantine restrictions.
Most netizens complained, arguing that using stickers to distinguish vaccinated and unvaccinated customers is discrimination.
But some supported the coffee shop’s action, noting they would be subject to a 1.5 million won fine if found violating quarantine restrictions.


Platinum Price Surges Past $2,000 as Demand and Supply Dynamics Tighten
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
Global Markets Rise as Tech Stocks Lead, Yen Strengthens, and Commodities Hit Record Highs
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Global Demand for Yuan Loans and Bonds Surges as China Pushes Currency Internationalization
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Why U.S. Coffee Prices Are Staying High Despite Trump’s Tariff Rollbacks
Wall Street Ends Higher as S&P 500, Nasdaq Extend Gains Ahead of Holiday Week
China Keeps Benchmark Lending Rates Steady as Economic Outlook Remains Cautious
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
U.S. Dollar Slips as Yen Finds Support on Intervention Signals and Geopolitical Risks Rise
China’s Power Market Revamp Fuels Global Boom in Energy Storage Batteries 



